Rubric Capital Management LP Amryt Pharma PLC Transaction History

Rubric Capital Management LP

  • $3.59 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 13, 2022
BUY
$6.3 - $10.86 $349,851 - $603,077
55,532 Added 1.57%
3,600,000 $29.8 Million
Q4 2021

Feb 14, 2022
BUY
$9.44 - $12.24 $2.71 Million - $3.52 Million
287,463 Added 8.83%
3,544,468 $38.3 Million
Q3 2021

Nov 12, 2021
BUY
$9.63 - $12.47 $31.4 Million - $40.6 Million
3,257,005 New
3,257,005 $39.2 Million

Others Institutions Holding AMYT

# of Institutions
5
Shares Held
142K
Call Options Held
0
Put Options Held
0
View Full List

About Amryt Pharma plc

AMYT Quotes by TradingView
  • Ticker AMYT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 64,177,000
  • Description
  • Amryt Pharma plc, a commercial-stage biopharmaceutical company, focuses on acquiring, developing, and commercializing various treatments to help improve the lives of patients with rare and orphan diseases. The company provides metreleptin, an adjunct to diet as replacement therapy to treat the complications of leptin deficiency in patients with ...
More about AMYT
Track This Portfolio

Track Rubric Capital Management LP Portfolio

Follow Rubric Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rubric Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Rubric Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email